Patents by Inventor Tao Sheng

Tao Sheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ion channel modulating compounds and uses thereof
    Patent number: 7875611
    Abstract: Ion channel modulating compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses a variety of in vitro and in vivo uses for the compounds and compositions, including the treatment of arrhythmia and the production of analgesia and local anesthesia.
    Type: Grant
    Filed: April 15, 2009
    Date of Patent: January 25, 2011
    Assignee: Cardiome Pharma Corp.
    Inventors: Allen I. Bain, Gregory N. Beatch, Cindy J. Longley, Bertrand M. C. Plouvier, Tao Sheng, Michael J. A. Walker, Richard A. Wall, Sandro L. Yong, Jeff Jiqun Zhu, Alexander B. Zolotoy
  • AMINOCYCLOHEXYL ETHER COMPOUNDS AND USES THEREOF
    Publication number: 20110004006
    Abstract: Aminocyclohexyl ether compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses uses for the compounds and compositions, including the treatment of arrhythmia.
    Type: Application
    Filed: July 9, 2010
    Publication date: January 6, 2011
    Applicant: CARDIOME PHARMA CORP.
    Inventors: Grace Jung, Bertrand M. C. Plouvier, Yuzhong Liu, Jeff Jiqun Zhu, Tao Sheng, Anthony G. M. Barrett, Lewis Siu Leung Choi, Doug Ta Hung Chou
  • EXTENSIBLE USER INTERFACE GENERATION
    Publication number: 20100313182
    Abstract: A data source extensibility model establishes extensibility points to allow a data source window or integrated development environment to work with new data source providers and/or new designer technologies and/or new UI controls. Various object/entity management techniques are provided to orchestrate which component is present in given conditions.
    Type: Application
    Filed: June 5, 2009
    Publication date: December 9, 2010
    Applicant: Microsoft Corporation
    Inventors: John Z. Chen, Antoine Cote, Shichao Hu, Tao Sheng Hu, Yang Cao, Yaohai Zheng
  • Aminocyclohexyl ether compounds and uses thereof
    Patent number: 7767830
    Abstract: Aminocyclohexyl ether compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses uses for the compounds and compositions, including the treatment of arrhythmia.
    Type: Grant
    Filed: March 23, 2007
    Date of Patent: August 3, 2010
    Assignee: Cardiome Pharma Corp.
    Inventors: Grace Jung, Bertrand M. C. Plouvier, Yuzhong Liu, Jeff Jiqun Zhu, Tao Sheng, Anthony G. M. Barrett, Lewis Siu Leung Choi, Doug Ta Hung Chou
  • SYNTHETIC PROCESS FOR AMINOCYCLOHEXYL ETHER COMPOUNDS
    Publication number: 20100152464
    Abstract: Methods for the preparation of stereoisomerically substantially aminocyclohexyl ether compounds such as trans-(1R,2R)-aminocyclohexyl ether compounds and/or trans-(1S,2S)-aminocyclohexyl ether compounds as well as various intermediates and substrates are disclosed.
    Type: Application
    Filed: November 18, 2005
    Publication date: June 17, 2010
    Applicant: CARDIOME PHARMA CORP.
    Inventors: Bertrand M. C. Plouvier, Doug Ta Hung Chou, Grace Jung, Lewis Siu Leung Choi, Tao Sheng, Anthony G. M. Barrett, Marco S. Passafaro, Martin Kurz, Daniel Moeckli, Pirmin Ulmann, Alfred Hedinger
  • HEDGEHOG SIGNALING PATHWAY PROTEINS AND USES THEREOF
    Publication number: 20100111955
    Abstract: The present invention discloses a component in the hedgehog signaling pathway that can be useful in the treatment and diagnosis of hedgehog signaling pathway associated disorders. In this regard, the present invention discloses that RanBPM regulated the stability of hedgehog signaling molecule, smoothened (SMO) and that inactivation of RanBPM by siRNA prevented growth and metastasis of cancer cells.
    Type: Application
    Filed: November 9, 2007
    Publication date: May 6, 2010
    Inventors: Jingwu Xie, Tao Sheng, Xiaoli Zhang
  • ION CHANNEL MODULATING COMPOUNDS AND USES THEREOF
    Publication number: 20100056603
    Abstract: Ion channel modulating compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses a variety of in vitro and in vivo uses for the compounds and compositions, including the treatment of arrhythmia and the production of analgesia and local anesthesia.
    Type: Application
    Filed: March 26, 2009
    Publication date: March 4, 2010
    Applicant: CARDIOME PHARMA CORP.
    Inventors: Gregory N. Beatch, Bertrand M.C. Plouvier, Tao Sheng, Michael J.A. Walker, Richard A. Wall, Sandro L. Yong, Jeff Jiqun Zhu, Alexander R. Zolotoy
  • ION CHANNEL MODULATING COMPOUNDS AND USES THEREOF
    Publication number: 20100029639
    Abstract: Ion channel modulating compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses a variety of in vitro and in vivo uses for the compounds and compositions, including the treatment of arrhythmia and the production of analgesia and local anesthesia.
    Type: Application
    Filed: April 15, 2009
    Publication date: February 4, 2010
    Applicant: CARDIOME PHARMA CORP.
    Inventors: Allen I. Bain, Gregory N. Beatch, Cindy J. Longley, Bertrand M. C. Plouvier, Tao Sheng, Michael J. A. Walker, Richard A. Wall, Sandro L. Yong, Jeff Jiqun Zhu, Alexander B. Zolotoy
  • Organic Compounds
    Publication number: 20090306107
    Abstract: The present invention relates to compounds that are useful to inhibit, regulate and/or modulate tyrosine and serine/threonine kinase and kinase-like proteins, such as RAF kinase, a serine/threonine kinase that functions in the MAP kinase signaling pathway. The application is also concerned with compositions which contain these compounds, and methods of using them to treat tyrosine and serine/threonine kinase and kinase-like dependent diseases, such as angiogenesis, cancer and cardiac hypertrophy, and with other subject matter.
    Type: Application
    Filed: March 17, 2006
    Publication date: December 10, 2009
    Applicant: NOVARTIS AG
    Inventors: Lawrence Blas Perez, Tao Sheng
  • Ion channel modulating compounds and uses thereof
    Patent number: 7534790
    Abstract: Ion channel modulating compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses a variety of in vitro and in vivo uses for the compounds and compositions, including the treatment of arrhythmia and the production of analgesia and local anesthesia.
    Type: Grant
    Filed: November 21, 2007
    Date of Patent: May 19, 2009
    Assignee: Cardiome Pharma Corp.
    Inventors: Allen I. Bain, Gregory N. Beatch, Cindy J. Longley, Bertrand M. C. Plouvier, Tao Sheng, Michael J. A. Walker, Richard A. Wall, Sandro L. Yong, Jeff Jiqun Zhu, Alexander B. Zolotoy
  • Ion channel modulating compounds and uses thereof
    Patent number: 7524879
    Abstract: Ion channel modulating compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses a variety of in vitro and in vivo uses for the compounds and compositions, including the treatment of arrhythmia and the production of analgesia and local anesthesia.
    Type: Grant
    Filed: June 4, 2007
    Date of Patent: April 28, 2009
    Assignee: Cardiome Pharma Corp.
    Inventors: Gregory N. Beatch, Bertrand M. C. Plouvier, Tao Sheng, Michael J. A. Walker, Richard A. Wall, Sandro L. Yong, Jeff Jiqun Zhu, Alexander R. Zolotoy
  • Trifluoromethyl substituted benzamides as kinase inhibitors
    Publication number: 20080096883
    Abstract: The invention relates to trifluoromethyl substituted benzamide compounds of the formula (I), pharmaceuticals comprising these compounds, their use as or for the manufacture of pharmaceuticals, particularly as inhibitors of protein kinases and/or the treatment of a condition, disorder or disease state mediated by a protein kinase activity and/or a proliferative disease, methods of treatment comprising administering the compounds, especially of therapeutic and prophylactic treatment, methods for the manufacture of the compounds and novel intermediates and partial steps for their synthesis.
    Type: Application
    Filed: August 10, 2005
    Publication date: April 24, 2008
    Inventors: Giorgio Caravatti, Pascal Furet, Patricia Imbach, Georg Martiny-Baron, Lawrence Blas Perez, Tao Sheng
  • ION CHANNEL MODULATING COMPOUNDS AND USES THEREOF
    Publication number: 20080070911
    Abstract: Ion channel modulating compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses a variety of in vitro and in vivo uses for the compounds and compositions, including the treatment of arrhythmia and the production of analgesia and local anesthesia.
    Type: Application
    Filed: November 21, 2007
    Publication date: March 20, 2008
    Applicant: CARDIOME PHARMA CORP.
    Inventors: Allen Bain, Gregory Beatch, Cindy Longley, Bertrand Plouvier, Tao Sheng, Michael Walker, Richard Wall, Sandro Yong, Jeff Zhu, Alexander Zolotoy
  • Aminocyclohexyl ether compounds and uses thereof
    Patent number: 7345087
    Abstract: Aminocyclohexyl ether compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses uses for the compounds and compositions, including the treatment of arrhythmia.
    Type: Grant
    Filed: March 30, 2006
    Date of Patent: March 18, 2008
    Assignee: Cardiome Pharma Corp.
    Inventors: Gregory N. Beatch, Bertrand M. C. Plouvier, Tao Sheng, Michael J. A. Walker, Richard A. Wall, Sandro L. Yong, Jeff Jiqun Zhu, Alexander B. Zolotoy
  • ION CHANNEL MODULATING COMPOUNDS AND USES THEREOF
    Publication number: 20080004333
    Abstract: Ion channel modulating compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses a variety of in vitro and in vivo uses for the compounds and compositions, including the treatment of arrhythmia and the production of analgesia and local anesthesia.
    Type: Application
    Filed: June 4, 2007
    Publication date: January 3, 2008
    Applicant: CARDIOME PHARMA CORP.
    Inventors: Gregory Beatch, Bertrand Plouvier, Tao Sheng, Michael Walker, Richard Wall, Sandro Yong, Jeff Zhu, Alexander Zolotoy
  • AMINOCYCLOHEXYL ETHER COMPOUNDS AND USES THEREOF
    Publication number: 20070254945
    Abstract: Aminocyclohexyl ether compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses uses for the compounds and compositions, including the treatment of arrhythmia.
    Type: Application
    Filed: March 23, 2007
    Publication date: November 1, 2007
    Applicant: CARDIOME PHARMA CORP.
    Inventors: Grace Jung, Bertrand Plouvier, Yuzhong Liu, Jeff Zhu, Tao Sheng, Anthony Barrett, Lewis Choi, Doug Chou
  • Aminocyclohexyl ether compounds and uses thereof
    Publication number: 20070197632
    Abstract: Aminocyclohexyl ether compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses uses for the compounds and compositions, including the treatment of arrhythmia.
    Type: Application
    Filed: August 11, 2005
    Publication date: August 23, 2007
    Applicant: Cardiome Pharma Corp
    Inventors: Gregory Beatch, Bertrand Plouvier, Tao Sheng, Michael Walker, Richard Wall, Sandro Yong, Jeff Zhu, Alexander Zolotoy
  • Ion channel modulating compounds and uses thereof
    Patent number: 7259184
    Abstract: Ion channel modulating compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses a variety of in vitro and in vivo uses for the compounds and compositions, including the treatment of arrhythmia and the production of analgesia and local anesthesia.
    Type: Grant
    Filed: January 27, 2006
    Date of Patent: August 21, 2007
    Assignee: Cardiome Pharma Corp.
    Inventors: Gregory N Beatch, Bertrand M C Plouvier, Tao Sheng, Michael J A Walker, Richard A Wall, Sandro L Yong, Jeff Jiqun Zhu, Alexander B Zolotoy
  • ION CHANNEL MODULATING COMPOUNDS AND USES THEREOF
    Publication number: 20070190156
    Abstract: Ion channel modulating compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses a variety of in vitro and in vivo uses for the compounds and compositions, including the treatment of arrhythmia and the production of analgesia and local anesthesia.
    Type: Application
    Filed: January 2, 2007
    Publication date: August 16, 2007
    Applicant: CARDIOME PHARMA CORP.
    Inventors: Gregory Beatch, Bertrand Plouvier, Tao Sheng, Michael Walker, Richard Wall, Sandro Yong, Jeff Zhu, Alexander Zolotoy
  • Aminocyclohexyl ether compounds and uses thereof
    Publication number: 20070099983
    Abstract: Aminocyclohexyl ether compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses uses for the compounds and compositions, including the treatment of arrhythmia.
    Type: Application
    Filed: October 31, 2003
    Publication date: May 3, 2007
    Applicant: Cardiome Pharma Corp.
    Inventors: G.M. Barrett, Lewis Choi, Dough Chou, Grace Jung, Bertrand Plouvier, Yuzhong Liu, Jeff Zhu, Tao Sheng